Cardiovascular Market Research Reports & Industry Analysis
Variations in heart size and position within the chest may be related to age, body size, shape, weight, or pathologic conditions of the heart and other nearby structures.
There has been considerable study into the role of inflammation in heart disease. Researchers have found the first direct evidence that reducing inflammation in coronary arteries decreases the risk of heart attacks as much as reducing cholesterol levels. This finding offers a new approach to preventing heart disease. Two studies showed that inflammation of the arteries can be reduced by more aggressive use of statins. New drugs that target inflammation that are measured by a marker called Creactive rotein (CRP) could have a large impact on cardiovascular health as well as a large financial gain for companies developing these products.
Cardiovascular Industry Research & Market Reports
-
Nanomedicine Market Research Report: Information by Modality (Treatments and Diagnostics), by Application (Drug Delivery, Diagnostic Imaging, Vaccines, Regenerative Medicine, and Implants), and by Indication (Oncological Diseases, Infectious Diseases, Cardiovascular Diseases, Orthopedic Diseases, Neurological Diseases, Urological Diseases, Ophthalmological Diseases, Immunological Diseases, and Others), by Molecule Type (Nanoparticles [Albumin Particles, Inorganic Nanoparticles, Lipid Nanoparticle, Liposomes, and Others], Nanoshells, Nanotubes, and Nanodevices), and by Region (North America, Europe, Asia-Pacific, and Rest of the World) Industry Forecast till 2032
... Diseases, Ophthalmological Diseases, Immunological Diseases, and Others), by Molecule Type (Nanoparticles [Albumin Particles, Inorganic Nanoparticles, Lipid Nanoparticle, Liposomes, and Others], Nanoshells, Nanotubes, and Nanodevices), and by Region (North America, Europe, Asia-Pacific, and Rest of the ... Read More
-
Global Dyslipidemia Market - 2024-2031
... 2024-2031. Dyslipidemia is a medical condition characterized by abnormal levels of lipids (fats) in the blood, which include cholesterol and triglycerides. Dyslipidemia is an umbrella term that encompasses various disorders related to lipid levels, including ... Read More
-
Citicoline Market Research Report Information by Product (Capsules, Tablets, Powder, Eye Drops, and Injection) by Application (Sports Nutrition, Personal Wellness, Treatment [Glaucoma, Stroke, Alzheimer disease, Channel (pression, and Others]), by Age Group (Pediatric, Adult, and Geriatric) by Distribution Channel (Online Channel, Offline Channel), by Region (North America, Europe, Asia-Pacific, and Rest of the World) Industry Forecast till 2032
... Geriatric) by Distribution Channel (Online Channel, Offline Channel), by Region (North America, Europe, Asia-Pacific, and Rest of the World) Industry Forecast till 2032 The Citicoline market was valued at USD 0.43 billion in 2023 and ... Read More
-
Global Antiplatelet Market: Analysis By Drug Class (Adenosine Diphosphate Receptor Inhibitors, Irreversible Inhibitors Cyclooxygenase, and Other Drug Classes), By Route of Administration (Oral and Injectable), By Distribution Channel (Drug Stores, Hospital Pharmacies, and Online Stores), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029
... By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029 - Report Summary Report Metrics Details Years Considered 2019-2029 Base Year 2023 Forecast Period 2024-2029 Page Count 146 Units Referenced US ... Read More
-
Cell and Gene Therapy Market Research Report Information by Therapy Type (Cell Therapy and Gene Therapy), Application (Cancer, Neurological Disorders, Cardiovascular Disorders, Rare Diseases, Ophthalmology, Blood Disorders and Others), and Region (North America, Europe, Asia-Pacific, and Rest of the World) Industry Forecast till 2032
... and Rest of the World) Industry Forecast till 2032 In 2023, the e-Visa market was estimated to be worth USD 933.4 million. With a compound annual growth rate (CAGR) of 11.1% from 2024 to 2032, ... Read More
-
Physiotherapy Equipment Market by Product (Equipment, Accessories), Application (Musculoskeletal, Neurological, Cardiovascular & Pulmonary, Pediatric & Gynecological Application), End User, Region - Global Forecast to 2029
... billion by 2029 from USD 20.13 billion in 2024, at a CAGR of 6.1 % during the forecast period. Lifestyle factors, such as lack of exercise and poor dieting, compounded by an ageing population, explain ... Read More
-
Global Prils Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Patient Monitoring Devices
... by 2030, growing at a CAGR of 7.4% over the analysis period 2023-2030. Blood Glucose Monitoring Devices, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$23.2 ... Read More
-
Embolotherapy
... of 7.5% over the analysis period 2023-2030. Embolic Agents, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$6.7 Billion by the end of the analysis period. ... Read More
-
Clinical Decision Support System Market Research Report Information by Component (Software, Services, and Hardware) By Product (Integrated CDSS and Standalone CDSS), By Model (Knowledge-Based CDSS and Non-Knowledge-Based CDSS), By Delivery Mode (On-Premise CDSS and Cloud-Based CDSS), By Mode of Advice (Active CDSS and Passive CDSS), By Setting (Inpatient Settings and Ambulatory Care Settings) By Type (Therapeutic Clinical Decision Support Systems and Diagnostic Clinical Decision Support Systems ), By Application (Advanced Clinical Decision Support Systems and Conventional Clinical Decision Support Systems), By Region (North America, Europe, Asia-Pacific, and Rest of the World) - Industry Forecast till 2032
... CDSS), By Mode of Advice (Active CDSS and Passive CDSS), By Setting (Inpatient Settings and Ambulatory Care Settings) By Type (Therapeutic Clinical Decision Support Systems and Diagnostic Clinical Decision Support Systems ), By Application (Advanced ... Read More
-
North America Pharmacokinetics Services Market Forecast to 2031 - Regional Analysis - by Drug Type (Small Molecule, Large Molecule, and Vaccines), Service Type (Pre-Clinical ADME and Human Studies, PK/PD Analysis and Reporting, Dosing Simulations, Risk Analysis, and Others), Therapeutic Application (Oncology, Infectious Diseases, Neurological Disorders, Autoimmune Diseases, Gynecological Disorders, Cardiovascular Diseases, Respiratory Disorders, and Others), and End User (Pharmaceutical and Biotechnology Companies, Contract Research Organization, and Others)
... Analysis, and Others), Therapeutic Application (Oncology, Infectious Diseases, Neurological Disorders, Autoimmune Diseases, Gynecological Disorders, Cardiovascular Diseases, Respiratory Disorders, and Others), and End User (Pharmaceutical and Biotechnology Companies, Contract Research Organization, and Others) The North America ... Read More
-
Middle East & Africa Pharmacokinetics Services Market Forecast to 2031 - Regional Analysis - by Drug Type (Small Molecule, Large Molecule, and Vaccines), Service Type (Pre-Clinical ADME and Human Studies, PK/PD Analysis and Reporting, Dosing Simulations, Risk Analysis, and Others), Therapeutic Application (Oncology, Infectious Diseases, Neurological Disorders, Autoimmune Diseases, Gynecological Disorders, Cardiovascular Diseases, Respiratory Disorders, and Others), and End User (Pharmaceutical and Biotechnology Companies, Contract Research Organization, and Others)
... Simulations, Risk Analysis, and Others), Therapeutic Application (Oncology, Infectious Diseases, Neurological Disorders, Autoimmune Diseases, Gynecological Disorders, Cardiovascular Diseases, Respiratory Disorders, and Others), and End User (Pharmaceutical and Biotechnology Companies, Contract Research Organization, and Others) The ... Read More
-
South & Central America Pharmacokinetics Services Market Forecast to 2031 - Regional Analysis - by Drug Type (Small Molecule, Large Molecule, and Vaccines), Service Type (Pre-Clinical ADME and Human Studies, PK/PD Analysis and Reporting, Dosing Simulations, Risk Analysis, and Others), Therapeutic Application (Oncology, Infectious Diseases, Neurological Disorders, Autoimmune Diseases, Gynecological Disorders, Cardiovascular Diseases, Respiratory Disorders, and Others), and End User (Pharmaceutical and Biotechnology Companies, Contract Research Organization, and Others)
... Simulations, Risk Analysis, and Others), Therapeutic Application (Oncology, Infectious Diseases, Neurological Disorders, Autoimmune Diseases, Gynecological Disorders, Cardiovascular Diseases, Respiratory Disorders, and Others), and End User (Pharmaceutical and Biotechnology Companies, Contract Research Organization, and Others) The ... Read More
-
Europe Pharmacokinetics Services Market Forecast to 2031 - Regional Analysis - by Drug Type (Small Molecule, Large Molecule, and Vaccines), Service Type (Pre-Clinical ADME and Human Studies, PK/PD Analysis and Reporting, Dosing Simulations, Risk Analysis, and Others), Therapeutic Application (Oncology, Infectious Diseases, Neurological Disorders, Autoimmune Diseases, Gynecological Disorders, Cardiovascular Diseases, Respiratory Disorders, and Others), and End User (Pharmaceutical and Biotechnology Companies, Contract Research Organization, and Others)
... and Others), Therapeutic Application (Oncology, Infectious Diseases, Neurological Disorders, Autoimmune Diseases, Gynecological Disorders, Cardiovascular Diseases, Respiratory Disorders, and Others), and End User (Pharmaceutical and Biotechnology Companies, Contract Research Organization, and Others) The Europe pharmacokinetics services ... Read More
-
2024 France Congestive Heart Failure (Chf) Treatment Devices Forecast (2025-2030 Outlook)-Market Opportunities Report
... the NAICS Healthcare industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
2024 United Kingdom Congestive Heart Failure (Chf) Treatment Devices Forecast (2025-2030 Outlook)-Market Opportunities Report
... within the NAICS Healthcare industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and ... Read More
-
2024 North America Congestive Heart Failure (Chf) Treatment Devices Forecast (2025-2030 Outlook)-Market Opportunities Report
... within the NAICS Healthcare industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and ... Read More
-
2024 India Congestive Heart Failure (Chf) Treatment Devices Forecast (2025-2030 Outlook)-Market Opportunities Report
... the NAICS Healthcare industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
2024 Asia-Pacific Congestive Heart Failure (Chf) Treatment Devices Forecast (2025-2030 Outlook)-Market Opportunities Report
... the NAICS Healthcare industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
2024 China Congestive Heart Failure (Chf) Treatment Devices Forecast (2025-2030 Outlook)-Market Opportunities Report
... the NAICS Healthcare industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
2024 Japan Congestive Heart Failure (Chf) Treatment Devices Forecast (2025-2030 Outlook)-Market Opportunities Report
... the NAICS Healthcare industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
2024 Europe Congestive Heart Failure (Chf) Treatment Devices Forecast (2025-2030 Outlook)-Market Opportunities Report
... the NAICS Healthcare industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
2024 Latin America Congestive Heart Failure (Chf) Treatment Devices Forecast (2025-2030 Outlook)-Market Opportunities Report
... within the NAICS Healthcare industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and ... Read More
-
2024 Germany Congestive Heart Failure (Chf) Treatment Devices Forecast (2025-2030 Outlook)-Market Opportunities Report
... the NAICS Healthcare industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
2024 United States Congestive Heart Failure (Chf) Treatment Devices Forecast (2025-2030 Outlook)-Market Opportunities Report
... within the NAICS Healthcare industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and ... Read More
Research Assistance
